Senegalese National Malaria Control Program
Awa Deme
PARMA-Hub is a Capacity Development program, and Awa’s role is to coordinate the analysis of samples collected from efficacy studies with the mission to strengthen malaria molecular surveillance on the African continent.
Baba Dieye
Baba is interested in malaria drug resistance specifically on phenotypic assays: routine drug susceptibility tests and survival assays. The phenotypic approach will help monitor the susceptibility of current antimalarial in use in Senegal and explore the effect of new mutations on parasite susceptibility to drugs.
Amy Gaye
Amy has a Ph.D. in Molecular Biology and is involved in genomic research and infectious disease. Her current focus is using molecular tools for malaria drug resistance surveillance in Senegal.
Daouda Ndiaye
Professor Ndiaye manages field site activities in Senegal for a number of collaborating institutions, including Harvard University, Tulane University, and the Broad Institute of MIT and Harvard. He serves as director of the International Research and Training Center on Infectious Pathogens and Genomics, and Senegal-Director of the Senegal Harvard Malaria Initiative.
Médoune Ndiop
Mr Ndiop is the lead economic planner at National Malaria Control Program, tasked with activities planning, surveillance, epidemiologic analysis, monitoring and evaluation of malaria. Starting in 2017, he has been the Co-Chair of Roll Back Malaria, an organization focusing on the monitoring and surveillance of malaria.
Aida Sadikh Badiane
Aida is interested in investigating the burden of non falciparum species in the context of malaria elimination in Senegal and the pathogens responsible of non-malarial fevers in Senegal.
Mouhamad Sy
Mouhamad Sy is a PhD student at the Laboratory of Parasitology at Hôpital Aristide le Dantec, Université Cheikh Anta Diop in Dakar, Sénégal. His research concerns Plasmodium falciparum diversity and drug resistance using specially target amplicon deep sequencing and metadata analysis. He has experience on malaria field research and on pathogen discovery using metagenomic sequencing.
Broad Institute
Amanda Lukens
Amanda Leads the Chemical Biology Project in the Wirth Laboratory. She leverages chemical biology, in vitro evolution, and whole genome sequencing to discover and interrogate chemically validated targets that can be used to guide drug design, identify drug targets in the malaria parasite, and to understand mechanisms of drug resistance.
Bronwyn MacInnis
